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Abstract Multiple sclerosis (MS) patients often complain
about balance problems when Romberg’s test and tandem
gait are normal. The aim of the study was to determine if
measures of trunk sway taken during a battery of stance
and gait tasks could be used to detect subclinical balance
disorders. We recorded trunk angular sway in the pitch and
roll directions from 20 MS patients (EDSS 1.4 ± 0.5) and
20 age- and gender-matched healthy controls (HCs), during
12 stance and gait tasks. We filmed 22 subjects simulta-
neously. Two neurologists assessed the videos, deciding
whether task performance was pathological. Sway mea-
sures were significantly different between patients and HCs
in eight out of 12 balance tasks. The most significant dif-
ferences between MS patients and HCs were pitch angle
range standing on one leg with eyes open on a firm surface
(mean 3.13 vs. 2.09, p = 0.005), and on a foam support
surface (mean 6.24 vs. 2.96, p = 0.006), pitch velocity
range walking 8 m with eyes closed (mean 75.5 vs. 50.2/s,
p \ 0.001) and pitch velocity range walking 3 m on heels
(mean 85.37 vs. 60.9/s, p = 0.002). Multivariate analysis
revealed a model with three tasks which detected balance
disorders in 84% of the MS patients and 90% of the HCs
correctly. The neurologists achieved accuracies of 30% for
the MS patients and 82% for the HCs. Using trunk sway
measures during stance and gait tasks is a sensitive
screening method for balance problems in MS patients, and
is more accurate than assessment by trained neurologists.
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Introduction
In multiple sclerosis (MS) patients detection of balance
deficits is challenging because MS patients often complain
about balance problems when the Romberg test is negative
and gait tests are normal [1]. Other clinical tests, for example,
the Berg Balance Scale and Tinetti Performance Oriented
Mobility Assessment, are also not sensitive enough to detect
minimal balance impairment in MS patients [2]. The main
problem with balance tests is the subjective character of the
assessment. Quantifying balance control may help to capture
MS related minimal or subclinical balance impairment.
There is no systematic study aimed to determine which
stance and gait tasks should be used to detect subclinical
balance disorders in MS patients. During the tasks we mea-
sured trunk angular sway because it can be used for quanti-
fying balance control during both types of tasks. To compose
a MS specific protocol, we selected tasks commonly used in
neurological examinations, those used in previous studies, as
well as those known from a parallel study [3] to be correlated
with disease severity in MS patients. As we wished to
establish if our detection technique was more accurate than
assessment of the same tasks by certified neurologists, we
compared the results of the discriminant model emerging
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from quantitative analysis of the trunk sway measures with
the assessment of the neurologists.
Methods
Protocol
We created a test battery of six stance tasks and six gait tasks.
The battery was performed without shoes. Tasks suggested
by Gensicke et al. [3] were standing on one leg with eyes
open on a firm surface and foam support surface for 20 s
(s1eo, s1eof). The Romberg test was included but with feet
together and performed for 30 s on a foam support surface
[4] with eyes open and closed—abbreviated s30ftfeo and
s30ftfec. Tandem stance tasks for 30 s eyes open and closed
(s30tseo, s30tsec) were chosen because these showed sig-
nificant differences between MS patients and HCs [4].
Walking eight tandem steps with eyes closed (w8tsec) is part
of the Fregly ataxia battery, a widely used clinical test for the
assessment of balance [5]. We also included an eyes open
tandem gait task (w8tsec) as suggested by Gensicke et al. [3].
The get up and go 3 m task (gug) was used in several studies
[6–8]. Finally, a number of tasks from standard clinical test
batteries were used; walking 8 m was performed with eyes
open and eyes closed (w8meo, w8mec), and walking for 3 m
on the heels (w3mheo). Task duration was as listed above for
stance tasks or until the task was completed for gait tasks.
The recording was stopped when the subject lost balance or
needed assistance from a spotter.
Subjects
Patients were recruited from outpatients of the Department
Neurology at the University Hospital Basel in Switzerland.
Inclusion criteria were diagnosis of MS according to the
McDonald criteria revised in 2005 [9] or clinically isolated
syndrome (CIS), age younger than 40 years and an EDSS
score B2. Sixteen MS patients (four male and 12 female) and
four females with CIS participated, with an average age of 31
(range 23–39) years, an average EDSS score of 1.4 ± 0.5,
and mean disease duration 6.8 ± 4.7 years. Twenty age-
and gender-matched healthy subjects acted as controls.
Participation was voluntary. All patients and HCs gave their
written informed consent to participate. The study was
approved by the ethical committee of the University of
Basel. The demographic data is presented in Table 1.
Measurement devices
Trunk movements were measured using a SwayStar
TM
device
(Balance International Innovations GmbH, Switzerland)
which contains two digital gyroscopes registering pitch
(posterior–anterior) and roll (medial–lateral) angular
velocities. The device is worn at the level of the lower back
(L3–L5), near the centre of mass. It is attached to a modified
motorcycle kidney belt which is strapped around the waist.
The sample rate is 100 Hz, and the drift of the gyroscopes is
approximately 1/h (less than the earth’s rotation). Twenty-
seconds of measurement therefore results in a drift of max-
imally 0.006.
Assessment by certified neurologists
Eleven subjects in each group were filmed while per-
forming the task battery. The videos were shown to two
certified neurologists unknown to each other. Their task
was to assess the videos not knowing whether the subject
was a healthy control or not, and to decide whether task
performance was pathological. Finally they were requested
to classify each subject as a MS patient or healthy control.
The overall group assignment of the neurologist was
compared to that of our discriminant procedure (see below)
by means of classification accuracies.
Assessment of subjective balance problems
Before the experiment started, the patients were asked to
complete a questionnaire: the Dizziness Handicap Index
(DHI) [10]. This is a self-report based on 25 questions
which quantify the subjective level of disability and
handicap in three subscales (emotional, functional and
physical). Questions could be answered with no (score 0),
sometimes (2), or yes (4), the final score ranged from 0 to
100. The higher the DHI, the more disability was experi-
enced by the patient [3, 11]. A score of zero on the DHI
was taken as no subjectively perceived balance problem.
All healthy control subjects had a score of zero, having
reported no subjective balance disorder.
Table 1 Subject characteristics
Patients Controls p-value
n 20 20 ns
Females/males 16/4 16/4 ns
Age (years, range) 30.9 (23–39) 30.9 (23–39) ns
Height (cm) 169.6 ± 11.6 170 ± 7.1 \0.05
Weight (kg) 72.5 ± 13.8 61.9 ± 7.2 \0.05
BMI 25.3 ± 4.7 21.4 ± 2.1 \0.05
EDSS (range) 1.4 ± 0.5 (0–2) –
Disease duration from
FS (years)
6.75 ± 4.67 –
Disease duration
from FD (years)
4.58 ± 2.96 –
BMI body mass index, FS first symptoms, FD first diagnosis, EDSS
Expanded Disability Status Scale
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Data processing and statistical analyses
We used the peak to peak roll and pitch, angle and velocity
ranges, as primary outcome measures to compare the MS
patients with the HCs (see Fig. 1). Roll and pitch angles of
the trunk sway data were derived from the recorded angular
velocities by trapezoidal integration. We performed Mann–
Whitney U tests between the peak to peak measures
because the data were not normally distributed. We
assumed that patients have more sway than healthy control
subjects, we used only one-tailed outcomes to decide
whether there is a significant difference or not. The sig-
nificant variables were entered into a stepwise discriminant
analysis in order to identify the most sensitive test protocol
and measures to distinguish between MS patients and
healthy controls. The F values of 3.8 for entry into, and 2.7
for removal from, the discriminant analysis were used. All
statistical analysis was performed with SPSS 19.0 for
Windows. The significance level was set at 0.05 and cor-
rected for multiple comparisons by using Bonferroni.
Results
Stance tasks
Three of the six stance tasks showed significant difference
between two groups (Table 2).
The tasks and variables with the most significant dif-
ferences were pitch angle range standing on one leg
with eyes open on a firm support surface (means 3.13
vs. 2.09, p = 0.005) and on a foam support surface
Fig. 1 Trunk angle and angular
velocity plots from typical
subjects for the task, standing on
one leg on a foam support
surface with eyes open. In the
angular velocity plots pitch
angular velocity (y-axis) is
plotted against roll velocity
(x-axis)
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(means 6.24 vs. 2.96, p = 0.006). Figure 1 shows exam-
ples of the eyes open on foam one-legged stance task. The
following three stance tasks s30tseo, s30tsec, s30ftfeo
showed no significant group differences (p [ 0.05) (Fig. 1).
Gait tasks
In contrast to the stance tasks five of the six gait tasks
showed significant differences between MS patients and
healthy control subjects (see Table 2). The most significant
differences were seen for the pitch velocity range walking
8 m with eyes closed (means 75.5 vs. 50.2/s, p \ 0.001)
and in the pitch velocity range walking 3 m on heels
(means 85.37 vs. 60.94/s, p = 0.002). Table 2 shows that
almost all the group differences in gait are for pitch angular
velocity ranges and not for angle ranges.
Discriminant analysis
Figure 2 provides scatter plots for each subject on com-
pletion of the discriminant analysis. The classification
function calculated was:
0.36 9 Pitch velocity range (w8mec) ? 0.81 Roll angle
range (s1eof) - 5.99 9 Roll angle range (gug) ? 0.464
(Fig. 2).
We performed the step-wise discriminant analysis with
all variables which were significant different based on
the Mann–Whitney U tests (see Table 2). Pitch velocity
range recorded during walking 3 m on heels, eyes open
emerged as the best discriminator in step 1, but it was
removed in step 4 due to correlations with the other
entered variables. The lowest F value from the ANOVA
analysis for the variables to enter the discriminant
function was 8.5 with 3.35 dof (p \ 0.001). The
approximate final F value for the MANOVA analysis of
group means for variables in the discriminant function
was 9.5 with 3.35 dof (p \ 0.001). When differentiating
the MS patients from the control group, the overall
classification was 87%. For patients the classification
accuracies was 84% and for healthy controls the classi-
fication accuracies was 90%. In Table 3 the details of
the discriminant analysis classification accuracy are
shown and compared to the neurologists classifications
(Table 3).
Table 2 Significant trunk sway
differences between patients
and controls
Results for the eight test
protocols with significant
differences (p \ 0.05) with
respect to the control group are
marked in bold text and by an
asterisk (*)
s1eo standing on one leg eyes
open, s30ftfec standing for 30 s
feet together on foam support
surface with eyes closed, s1eof
standing on one leg with eyes
open on foam support surface,
w8tsec tandem walk for 8 s with
eyes open, gug get up and go
3 m task, w8meo walking 8 m
with eyes open, w8mec walking
8 m with eyes closed, w3mheo
walking for 3 m on the heels
Protocol Angle range () Velocity range (/s)
Patients Controls Patients Controls
s1eo
Roll 2.59 (1.59) 1.89 (0.74) 9.49 (7.24) 6.71 (5.45)
Pitch 3.13 (1.80)* 2.09 (0.81) 12.60 (13.54)* 8.33 (9.78)
s30ftfec
Roll 2.93 (1.08) 2.61 (0.94) 10.81 (5.69) 8.62 (3.45)
Pitch 2.89 (0.95) 2.60 (0.71) 9.47 (3.56)* 7.98 (3.76)
s1eof
Roll 9.20 (7.58)* 3.92 (4.75) 29.24 (23.87)* 14.00 (12.19)
Pitch 6.24 (4.82)* 2.96 (2.04) 21.67 (16.93)* 10.94 (6.04)
w8tsec
Roll 11.35 (4.37) 10.42 (3.98) 46.71 (12.60) 41.46 (14.87
Pitch 10.00 (5.17) 8.82 (4.11) 47.94 (15.19)* 37.51 (15.73)
gug
Roll 5.02 (1.07)* 5.75 (1.42) 45.50 (15.50) 44.05 (17.14)
Pitch 37.49 (5.97) 36.40 (7.65) 130.49 (36.80) 140.56 (35.93)
w8meo
Roll 5.86 (0.87) 6.29 (1.77) 61.83 (21.66) 58.19 (15.14)
Pitch 9.27 (2.19) 9.45 (3.22) 71.46 (23.99)* 56.87 (13.35)
w8mec
Roll 6.07 (1.32) 5.89 (1.42) 56.70 (20.05) 53.21 (12.14)
Pitch 9.60 (2.00) 9.56 (2.40) 75.53 (30.94)* 50.23 (13.34)
w3mheo
Roll 5.68 (1.67) 5.52 (1.58) 59.16 (19.50) 53.29 (9.08)
Pitch 8.86 (3.06) 7.81 (2.30) 85.37 (26.47)* 60.94 (13.98)
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Comparison between neurologists’ assessments
and discriminant analysis
The first neurologist had classification accuracies of 30%
for MS patients and 82% for controls, an overall score of
57%, and the second neurologist had classification accu-
racies of 27% for MS patients and 45% for controls, an
overall score of 36% (see Table 3). Walking eight tandem
steps with eyes closed was mostly seen as pathological in
HCs (11 times), followed by tandem stance with eyes
closed (seven times) and standing on one leg on foam with
eyes open (five times). The tasks of our discriminant model
were assessed six times as pathological in healthy controls
by the neurologists.
Subjective balance problems
Eleven (55%) of the 20 patients had a DHI score of [0.
They answered one or more questions with at least
‘‘sometimes’’ and, based on this criterion, classified
themselves subjectively as having a balance problem. Our
discriminant model confirmed the presence of balance
disorders in nine of these 11 patients. Only two of these
patients had a positive Romberg result, the same two
patients identified as pathological by the neurologists.
Among the patients who stated they had no balance prob-
lems in the DHI questionnaire (zero score), one patient who
also had a negative Romberg test was classified as a control
with both techniques neurologist’s selection and our dis-
criminant analysis.
Discussion
The main outcome of our study was that among 12 clinical
tests, standing on one leg eyes open on a foam support
surface, walking 8 m with eyes closed and get up from a
stool and go 3 m emerged as the best clinical test battery to
screen for subclinical balance disorders in MS patients.
This mix of a stance, gait and the get up and go task covers
different aspects of balance control. This test battery is able
to detect subclinical balance problems in MS patients more
accurately than the standard neurological examination
using the Romberg test, normal walking with eyes open,
and the tandem gait test with eyes open. In this study the
sway measures of healthy subjects without any balance
problems served as the comparison (‘‘gold’’) standard.
It is an open question what should serve as the standard
for comparison. If we had taken the patients subjective
assessments based on the DHI scores higher than zero, then
our model identified 82% of these patients correctly, a
similar figure to the 84% correct identification across all
patients. This is a question that needs to be explored in
future studies. Two neurologists, independent from each
other and blinded to the clinical data of the patients, were
requested to attempt to select the patients on the basis of
presumed balance deficits by watching videos of the
patients and healthy controls performing the 12 balance
tasks of the study. However, they only achieved accuracies
of 27–30% in detecting balance deficits, whereas assess-
ment of sway measures in the three tests mentioned above
could detect balance disorders in 84% of the patients.
Fig. 2 Scatter plots of patient and healthy control discriminant
function values
Table 3 Classification tables for discriminant analysis model and
neurologist rating
Classification by discriminant model Actual status
Patient Control Total
Predicted group for discriminant
model
Patient 16 (85%) 2 18
Control 3 18 (90%) 21
Total 19 20 39
Selection by neurologist 1
Predicted group for neurologist 1
Patient 3 (30%) 2 5
Control 7 9 (82%) 16
Total 10 11 21
Selection by neurologist 2
Predicted group for neurologist 2
Patient 3 (27%) 6 9
Control 8 5 (45%) 13
Total 11 11 22
Number and percentages of patients and controls with correct and
incorrect classifications are listed
J Neurol (2012) 259:1413–1419 1417
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Currently, the Romberg test is mostly used clinically to
identify an abnormal balance control in neurological
patients. Beside the Romberg test, there are more clinically
based tests, e.g. Berg Balance Scale and Tinetti Perfor-
mance Oriented Mobility Assessment. These tests are
partly based on subjective ratings and provide no guarantee
that there is no balance problem when the assessment is
negative. There are MS patients who complain about
subjective discomfort of balance even if there is no clinical
evidence of any balance problem [1]. Detecting minimal
impairment of balance based on observation is not easy as
confirmed by our neurologists who examined the videos.
Perhaps their task would have been easier if they were
informed, based on the results of our discriminant analysis,
to concentrate on excessive trunk roll angle for the one-
legged stance task on foam, increased trunk pitch velocities
during walking with eyes closed, and reduced trunk roll
angles for the get up and go task. Presumably, for them to
judge the greater trunk pitch velocity in MS patients during
walking would be difficult. In this respect, the question also
arises whether the pitch velocity during walking on the
heels might be easier to employ than reduced roll during
the get up and go test. The former measure replaced the
latter in the step-wise discriminant analysis.
The test battery we started with contained six different
stances and six gait tasks; in eight of these tasks we detected
a difference in trunk sway between MS patients and healthy
controls. Five of these were gait tasks. This corresponds to
findings of Karst et al. [2], who concluded, based on litera-
ture that balance control during stance is less discriminating
than during gait. Our analysis revealed that standing on one
leg on foam with eyes open showed the greatest difference in
trunk sway between MS patients and healthy controls, thus
confirming the findings in Gensicke et al. [3]. In MS, pro-
prioceptive deficits delay balance corrections [12]. Thus, it
was not surprising that many tests showing significant dif-
ferences relied on further reducing the effectiveness of
proprioceptive inputs using a foam support or placing greater
reliance on this input by performing the tests eyes closed.
Thus, it appears easier to detect the minor subclinical bal-
ance problems during stance when the effect of the problem,
a greater trunk sway, is enhanced by decreasing the propri-
oceptive input or removing the possibility for visual com-
pensation of weakened proprioceptive inputs.
We assumed that MS patients would have more trunk
sway when performing the stance and gait tasks. In Table 2,
where the differences are presented, there is only one task
where patients had less trunk sway comparing to healthy
subjects. A significant lower trunk sway was seen for the roll
angle range in the get up and go 3 m task. This is also one of
the discriminators in our screening model. It should be noted
that this is the task with the greatest sway angles. Karst et al.
[2] found in their study, on voluntary leaning and reaching, a
smaller displacement of the centre of pressure in minimally
impaired MS patients compared to healthy controls. They
suggested that the MS patients were instinctively aware of
their limitations and found a strategy to achieve the same
movements, but with less displacement of the centre of
pressure, and thus with less trunk sway. Martin et al. [13]
found also a worse performance (smaller reaching move-
ments) of MS patients in voluntary reaching compared to
HCs. It is possible that MS patients attempt to keep their
lateral instability to a minimum during the get up phase.
The discriminant model had a quite reasonable overall
classification accuracy of 87%. It was better than the neu-
rologists, who had overall accuracies of 57 and 36%. Our
neurologists classified 82 and 45% of the controls correctly
compared to our model with 90%. However, the classifi-
cation of 30 and 27% for the patients is much worse then the
84% of our discriminant model. The neurologists marked
different tasks as pathological compared to our discriminant
model, except for s1feo. The tasks s30tsec and w8tsec were
more often marked as pathological for incorrectly classified
healthy subjects. It appears that the range of normal trunk
sway for these tasks is greater than the neurologists esti-
mated. With the three task battery of tests we developed
using trunk sway measures of balance control; we have an
objective measurement to detect balance disorder in mini-
mally impaired MS patients. In the patient group more
patients were recognized as such. Not only is the better
classification an advantage from the point of screening for
MS, but it is also an objective measurement which could be
used to monitor the effect of medication.
In our patient group, 11 of the 20 patients classified
themselves subjectively as having a balance problem. Only
two patients were classified as a patient by the neurologists,
the same two with positive Romberg results. However, nine
of these 11 including the two with positive Romberg results
were classified as having a balance problem with our dis-
criminant technique. This confirms two previous findings.
Firstly that the Romberg test is not sensitive in detecting
subclinical balance disorders [1, 2], and secondly that
clinical balance tests do not identify the balance problems
of MS patients with subjective balance impairment [14].
A number of factors may have influenced our compar-
isons between MS patients and controls. Our classification
percentages of MS patients can be viewed as sensitivity
and specificity measures as all patients had MS according
to actual diagnosis criteria [9]. Matched controls did not
have an MRI. Thus, we can not exclude the possibility that
the controls had lesions in the CNS affecting balance
system subclinically. However, the prevalence of subclin-
ical MS lesions in the brain of 20 healthy subjects can be
estimated as insignificant small [15]. An overall compu-
tation of sensitivity of our discriminant technique would
require MRIs for the controls. Our healthy controls are
1418 J Neurol (2012) 259:1413–1419
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age- and gender-matched with the MS patients (see
Table 2). Height has no effect on trunk sway over the age
range of the patients [16], but the distribution of weight
may influence the stability, the trunk sway, and thus the
balance of a person. We did not match the healthy controls
according to weight, but to age and gender. The healthy
controls had, on average, a significant lower BMI, based on
a significant lower weight. Some patients could not main-
tain their balance during the whole task. We only included
data taken when subjects were maintaining their balance.
Some of the stance tasks had, therefore, shorter durations
than those of normal subjects. One patient could not do
several tasks, including the discriminating tasks entered
into the discriminant model. Therefore, we only had 19
patients in the discriminant analysis who were classified.
Although we have patients with a low EDSS and relative
short disease duration, some are taking MS related medi-
cation which may have effect on their balance. In total 14
patients were on medication (natalizumab seven, interferon
beta 1b five, and others two). However, in clinical phase III
studies vertigo and/or balance problems were not reported
to be significantly higher in the treatment group compared
with placebo [17–22].
In conclusion, using trunk sway measures during stance
and gait tasks provides a sensitive means of screening for
balance problems in mildly affected MS patients, and is
more accurate than the current practice, assessment by a
certified neurologist. However, further work will need to
examine whether this technique can be used for follow-up
of patients and assessment of potentially effective symp-
tomatic physical or drug therapy.
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